SYSTEMIC TREATMENT OF KAPOSIS-SARCOMA - CURRENT STATUS AND FUTURE-DIRECTIONS

被引：32

作者：

LILENBAUM, RC

RATNER, L

机构：

[1] WASHINGTON UNIV,SCH MED,DEPT MED,DIV HEMATOL & ONCOL,ST LOUIS,MO 63110

[2] WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110

来源：

关键词：

HIV; TAT; CYTOKINES; ANGIOGENESIS; CHEMOTHERAPY; INTERFERON;

D O I：

10.1097/00002030-199402000-00001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：141 / 151

页数：11

共 97 条

[1] ARMAND JP, 1989, SEM ONCOL S4, V16, pS41
[2] TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III)
ARYA, SK
GUO, C
JOSEPHS, SF
WONGSTAAL, F
[J]. SCIENCE, 1985, 229 (4708) : 69 - 73
[3] KAPOSIS SARCOMA AMONG PERSONS WITH AIDS - A SEXUALLY-TRANSMITTED INFECTION
BERAL, V
PETERMAN, TA
BERKELMAN, RL
JAFFE, HW
[J]. LANCET, 1990, 335 (8682) : 123 - 128
[4] Billington D C, 1991, Drug Des Discov, V8, P3
[5] BOYLE MJ, 1993, 9 INT C AIDS BERL
[6] PROGRESSION OF KAPOSIS-SARCOMA UNDER A COMBINED INTERFERON-BETA AND INTERFERON-GAMMA THERAPY IN AIDS PATIENTS
BROCKMEYER, NH
MERTINS, L
GOOS, M
[J]. KLINISCHE WOCHENSCHRIFT, 1990, 68 (24): : 1229 - 1229
[7] THE SAFETY OF INTRAVENOUS CHEMOTHERAPY AND ZIDOVUDINE WHEN TREATING EPIDEMIC KAPOSIS SARCOMA
BRUNT, AM
GOODMAN, AG
PHILLIPS, RH
YOULE, MS
GAZZARD, BG
[J]. AIDS, 1989, 3 (07) : 457 - 460
[8] CHACHOUA A, 1987, CANCER TREAT REP, V71, P775
[9] CHEW T, 1993, 9 INT C AIDS BERL
[10] A PHASE-I/II TRIAL OF ZIDOVUDINE, INTERFERON-ALPHA, AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
DAVEY, RT
DAVEY, VJ
METCALF, JA
ZURLO, JJ
KOVACS, JA
FALLOON, J
POLIS, MA
ZUNICH, KM
MASUR, H
LANE, HC
[J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (01) : 43 - 52